These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 21948683
1. [Prospective study of the correlation of ultrasonography and CA125 in the management of ovarian cysts: a study of 77 cases]. Mathlouthi N, Ben Ayed B, Dhouib M, Chaabene K, Trabelsi K, Amouri H, Guermazi M. Tunis Med; 2011; 89(8-9):686-92. PubMed ID: 21948683 [Abstract] [Full Text] [Related]
2. Laparoscopic treatment of ovarian cysts in adolescents and young adults. Seckin B, Ozdener T, Tapisiz OL, Batioğlu S. J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):300-3. PubMed ID: 21715192 [Abstract] [Full Text] [Related]
3. Pre-operative prediction of serum CA125 level in women with ovarian masses. Benjapibal M, Neungton C. J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413 [Abstract] [Full Text] [Related]
4. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses. Moro F, Pasciuto T, Djokovic D, Di Legge A, Granato V, Moruzzi MC, Mancari R, Zannoni GF, Fischerova D, Franchi D, Scambia G, Testa AC. Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587 [Abstract] [Full Text] [Related]
5. Serum C-reactive protein in the differential diagnosis of ovarian masses. Hefler-Frischmuth K, Hefler LA, Heinze G, Paseka V, Grimm C, Tempfer CB. Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929 [Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts. Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M. Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055 [Abstract] [Full Text] [Related]
7. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L, Chang XH, Ye X, Zhu LR, Zhao Y, Tian L, Cheng HY, Li XP, Zhang H, Liao QP, Fu TY, Cheng YX, Cui H. Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [Abstract] [Full Text] [Related]
9. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923 [Abstract] [Full Text] [Related]
10. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors]. Liu YN, Ye X, Cheng HY, Cheng YX, Fu TY, Chen J, Chang XH, Cui H. Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446 [Abstract] [Full Text] [Related]
11. Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels. Chao A, Lee LY, Hsueh C, Lin CY, Tsai CL, Chao AS, Lin CT, Chou HH, Chang TC, Wang TH. Taiwan J Obstet Gynecol; 2013 Jun; 52(2):185-91. PubMed ID: 23915849 [Abstract] [Full Text] [Related]
12. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis. Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245 [Abstract] [Full Text] [Related]
13. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer. Nakae M, Iwamoto I, Fujino T, Maehata Y, Togami S, Yoshinaga M, Douchi T. J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622 [Abstract] [Full Text] [Related]
14. [Adnexal masses management: a prospective multicentric observational study]. Huchon C, Bats AS, Bensaïd C, Junger M, Nos C, Chatellier G, Lécuru F. Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176 [Abstract] [Full Text] [Related]
15. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors. Miyagi E, Maruyama Y, Mogami T, Numazaki R, Ikeda A, Yamamoto H, Hirahara F. Int J Clin Oncol; 2017 Feb; 22(1):118-125. PubMed ID: 27623814 [Abstract] [Full Text] [Related]
16. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Van Huffel S, Valentin L, International Ovarian Tumor Analysis Group. J Clin Oncol; 2005 Dec 01; 23(34):8794-801. PubMed ID: 16314639 [Abstract] [Full Text] [Related]
17. [Management of dermoid ovarian cysts. Report of 58 cases]. Chechia A, Koubaa A, Makhlouf T, Messaoudi Y, Terras K, Riahi J. Tunis Med; 2002 Mar 01; 80(3):131-5. PubMed ID: 12355638 [Abstract] [Full Text] [Related]
18. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K. Gynecol Oncol; 2006 Sep 01; 102(3):542-5. PubMed ID: 16510173 [Abstract] [Full Text] [Related]
19. The diagnosis of functional ovarian cysts using transvaginal ultrasound combined with clinical parameters, CA125 determinations, and color Doppler. Guerriero S, Ajossa S, Lai MP, Alcazar JL, Paoletti AM, Marisa O, Melis GB. Eur J Obstet Gynecol Reprod Biol; 2003 Sep 10; 110(1):83-8. PubMed ID: 12932878 [Abstract] [Full Text] [Related]
20. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression. Carico E, Chicchirichi R, Atlante M, Giovagnoli M, Vecchione A. Anticancer Res; 1995 Sep 10; 15(2):631-4. PubMed ID: 7763049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]